Accelerated neoatherosclerosis in a heart transplant recipient
Cardiac allograft vasculopathy is characterized by the absence of lipid-rich plaques. However, transplant recipients may also develop lesions that resemble traditional atherosclerosis. Tacrolimus and everolimus, which are commonly used in transplant recipients, are associated to proatherogenic side...
Main Authors: | Rafael Romaguera, Josep Gómez-Lara, Joan A. Gómez-Hospital |
---|---|
Format: | Article |
Language: | English |
Published: |
Permanyer
2019-02-01
|
Series: | REC: Interventional Cardiology (English Ed.) |
Online Access: | https://recintervcardiol.org/en/index.php?option=com_content&view=article&id=109 |
Similar Items
-
Very late thrombosis induced by neoatherosclerosis in bioresorbable stent
by: Guillem Muntané-Carol, et al.
Published: (2019-02-01) -
Neoatherosclerosis in the stent
by: A. A. Komkov, et al.
Published: (2015-12-01) -
Neoatherosclerosis in the stent
by: A. A. Komkov, et al.
Published: (2015-12-01) -
Does a Drug-Coated Balloon Accelerate Neoatherosclerosis?Novel Teaching Point
by: Hiroyoshi Mori, MD, et al.
Published: (2020-07-01) -
Neoateroesclerosis precoz en un paciente con trasplante cardiaco
by: Rafael Romaguera, et al.
Published: (2019-02-01)